Discover Opportunities months before the RFP drops
Learn more →Retrieving contract details... Hang tight!
See what competitors charge and their contract structure
Spot renewal opportunities 6-12 months before expiration
Analyze buyer's purchasing history and vendor preferences
Track expiration dates across all your target accounts
Reach decision-makers before renewal with competitive intel
Our customers win 3x more contract renewals and replacements
Verified decision-maker contacts
Winning vendor information
Budget & renewal data
Clean & enrich your CRM automatically
Track contract spending & renewal dates
Analyze historical pricing trends
Identify upcoming opportunities
Get complete source documentation & analysis
FDA Office of Acquisition Grant Services
This contract includes 1 purchase order from Aug 16, 2024 to Aug 16, 2024
| Buyer | Vendor | Issued Date | Quantity |
|---|---|---|---|
| FDA Office of Acquisition Grant Services | THE CRITICAL PATH INSTITUTE | Aug 16, 2024 | 1 |
Full Purchase Intelligence Available
Get complete pricing, descriptions, and financial details for all 1 purchase orders
Unlock Full Details →See what competitors charge and their contract structure
Spot renewal opportunities 6-12 months before expiration
Analyze buyer's purchasing history and vendor preferences
Track expiration dates across all your target accounts
Reach decision-makers before renewal with competitive intel
Our customers win 3x more contract renewals and replacements
No public files available for this contract.
Contract documentation may be available through official government sources or agency portals. Starbridge can help you track down and retrieve these files.
FDA Office of Acquisition Grant Services
THIS IS A COST REIMBURSEMENT CONTRACT TO ACQUIRE SERVICES FOR DEVELOPMENT OF A PARENTERAL CHALLENGE MODEL OF SYSTEMIC BOTULINUM NEUROTOXIN INTOXICATION IN RABBITS TO SUPPORT THE ADVANCEMENT OF CANDIDATE THERAPEUTIC MEDICAL COUNTERMEASURES.
Effective Date
Jun 29, 2023
Expires
Effective: Jun 29, 2023
FDA Office of Acquisition Grant Services
Expires:
THIS IS A COST REIMBURSEMENT CONTRACT TO ACQUIRE SERVICES FOR DEVELOPMENT OF A PARENTERAL CHALLENGE MODEL OF SYSTEMIC BOTULINUM NEUROTOXIN INTOXICATION IN RABBITS TO SUPPORT THE ADVANCEMENT OF CANDIDATE THERAPEUTIC MEDICAL COUNTERMEASURES.
ActiveFDA Office of Acquisition Grant Services
THE PURPOSE OF THIS CONTRACT IS TO CONDUCT RESEARCH AND DEVELOP TOOLS TO STRENGTHEN POST-MARKET SURVEILLANCE OF FDA-REGULATED PRODUCTS. THE OBJECTIVE IS TO APPLY ADVANCED ANALYTICS AND HYBRID ARTIFICIAL INTELLIGENCE TO IMPROVE RISK IDENTIFICATION USI
Effective Date
Sep 8, 2025
Expires
Effective: Sep 8, 2025
FDA Office of Acquisition Grant Services
Expires:
THE PURPOSE OF THIS CONTRACT IS TO CONDUCT RESEARCH AND DEVELOP TOOLS TO STRENGTHEN POST-MARKET SURVEILLANCE OF FDA-REGULATED PRODUCTS. THE OBJECTIVE IS TO APPLY ADVANCED ANALYTICS AND HYBRID ARTIFICIAL INTELLIGENCE TO IMPROVE RISK IDENTIFICATION USI
ActiveFDA Office of Acquisition Grant Services
THE FOOD AND DRUG ADMINISTRATION (FDA) IS RESPONSIBLE FOR PROTECTING THE PUBLIC HEALTH BY ASSURING THE SAFETY, EFFICACY, AND SECURITY OF HUMAN AND VETERINARY DRUGS, BIOLOGICAL PRODUCTS, MEDICAL DEVICES, OUR NATION?S FOOD SUPPLY, COSMETICS, AND PRODUC
Effective Date
Sep 8, 2025
Expires
Effective: Sep 8, 2025
FDA Office of Acquisition Grant Services
Expires:
THE FOOD AND DRUG ADMINISTRATION (FDA) IS RESPONSIBLE FOR PROTECTING THE PUBLIC HEALTH BY ASSURING THE SAFETY, EFFICACY, AND SECURITY OF HUMAN AND VETERINARY DRUGS, BIOLOGICAL PRODUCTS, MEDICAL DEVICES, OUR NATION?S FOOD SUPPLY, COSMETICS, AND PRODUC
ActiveFDA Office of Acquisition Grant Services
THIS REQUIREMENT IS FOR THE GENERATION OF A BAA TO ADDRESS THE ONGOING GROWTH IN CONTINUOUS MANUFACTURING WITHIN CELL LINES. THIS REQUIREMENT IS BEING FUNDED THROUGH THE PRESIDENT'S TARGET INCREASE FOR FOCUS ON ADVANCE MANUFACTURING AND WILL FOC
Effective Date
Sep 18, 2024
Expires
Effective: Sep 18, 2024
FDA Office of Acquisition Grant Services
Expires:
THIS REQUIREMENT IS FOR THE GENERATION OF A BAA TO ADDRESS THE ONGOING GROWTH IN CONTINUOUS MANUFACTURING WITHIN CELL LINES. THIS REQUIREMENT IS BEING FUNDED THROUGH THE PRESIDENT'S TARGET INCREASE FOR FOCUS ON ADVANCE MANUFACTURING AND WILL FOC
ActiveSee who's winning contracts, track spending trends, and identify your best opportunities before your competition.
Schedule Your Demo →Verified decision-maker contacts
Winning vendor information
Budget & renewal data
Clean & enrich your CRM automatically
Track contract spending & renewal dates
Analyze historical pricing trends
Identify upcoming opportunities
Get complete source documentation & analysis